Matches in DBpedia 2016-04 for { ?s ?p "Rüdiger Klein (born March 24, 1958 in Nickenich) is a German neurobiologist. He is director at the Max Planck Institute of Neurobiology and head of the department Molecules - Signaling - Development.Rüdiger Klein studied biology at the universities of Marburg and Tübingen and at the Juniata College (USA). He gained his PhD at the University of Tübingen and worked as a post-doctoral researcher at the National Cancer Institute at Frederick (NCI-Frederick) (USA) and at the Bristol-Myers Squibb Pharmaceutical Research Institute (USA). Afterwards, he led a junior research group at the European Molecular Biology Laboratory (EMBL) in Heidelberg. In 2001, he was appointed director at the Max Planck Institute of Neurobiology."@en }
Showing triples 1 to 2 of
2
with 100 triples per page.
- Rüdiger_Klein abstract "Rüdiger Klein (born March 24, 1958 in Nickenich) is a German neurobiologist. He is director at the Max Planck Institute of Neurobiology and head of the department Molecules - Signaling - Development.Rüdiger Klein studied biology at the universities of Marburg and Tübingen and at the Juniata College (USA). He gained his PhD at the University of Tübingen and worked as a post-doctoral researcher at the National Cancer Institute at Frederick (NCI-Frederick) (USA) and at the Bristol-Myers Squibb Pharmaceutical Research Institute (USA). Afterwards, he led a junior research group at the European Molecular Biology Laboratory (EMBL) in Heidelberg. In 2001, he was appointed director at the Max Planck Institute of Neurobiology.".
- Q108286 abstract "Rüdiger Klein (born March 24, 1958 in Nickenich) is a German neurobiologist. He is director at the Max Planck Institute of Neurobiology and head of the department Molecules - Signaling - Development.Rüdiger Klein studied biology at the universities of Marburg and Tübingen and at the Juniata College (USA). He gained his PhD at the University of Tübingen and worked as a post-doctoral researcher at the National Cancer Institute at Frederick (NCI-Frederick) (USA) and at the Bristol-Myers Squibb Pharmaceutical Research Institute (USA). Afterwards, he led a junior research group at the European Molecular Biology Laboratory (EMBL) in Heidelberg. In 2001, he was appointed director at the Max Planck Institute of Neurobiology.".